"Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells".
Amin GolestaniAtefeh RahimiMahsa NajafzadehMahtab SayadiSeyed Mehdi SajjadiPublished in: Molecular biology reports (2024)
Our data suggest that IM shows better therapeutic efficacy at lower doses when combined with ATX and/or CRC.